Similar articles

• [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].

  Schütt C, Eggers G, Schröder I, Kruse H, Schulz M, Blau HJ. Schütt C, et al. Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(5):677-84. Folia Haematol Int Mag Klin Morphol Blutforsch. 1983. PMID: 6198251 German.
• Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.

  Schut BJ, Dooren LJ, Uittenbogaart CH, Schellekens PT, Eijsvoogel VP. Schut BJ, et al. Immunology. 1979 Jan;36(1):1-12. Immunology. 1979. PMID: 369991 Free PMC article. Clinical Trial.
• Randomized trial of transfer factor treatment of human warts.

  Stevens DA, Ferrington RA, Merigan TC, Marinkovich VA. Stevens DA, et al. Clin Exp Immunol. 1975 Sep;21(3):520-4. Clin Exp Immunol. 1975. PMID: 1106927 Free PMC article. Clinical Trial.
• [Transfer factor (its use in immunotherapy of neoplasms and other diseases)].

  Zduńczyk A. Zduńczyk A. Wiad Lek. 1980 Jun 1;33(11):877-81. Wiad Lek. 1980. PMID: 6999743 Review. Polish. No abstract available.
• [Treatment of immunologic deficiency conditions by means of transfer factor].

  Kobielowa Z. Kobielowa Z. Pediatr Pol. 1975 Nov;50(11):1393-7. Pediatr Pol. 1975. PMID: 1103073 Review. Polish. No abstract available.